We are live on ! Find out more

Utah Medical Products

UTMD

Market cap $226M

71.10 USD

+0.39

0.55%

At close Updated Sep 4, 4:00 PM EDT

1 day

0.55%

5 days

-1.75%

1 month

-1.66%

3 months

4.57%

6 months

7.4%

Year to date

25.84%

1 year

13.31%

5 years

-21.04%

10 years

11.95%

About: Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.

Employees: 152

Healthcare Medical Instruments & Supplies

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 75%

Negative 25%

Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK

SALT LAKE CITY, UT / ACCESS Newswire / August 31, 2026 / Femcare Ltd. ("Femcare"), a wholly-owned subsidiary of Utah Medical Products, Inc. (Nasdaq:UTMD), announces that it has purchased the entire ordinary share capital of Orion Medical Supplies Ltd ("ORION") of the United Kingdom.

Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK

Utah Medical Products, Inc. Announces Quarterly Dividend

SALT LAKE CITY, UT / ACCESS Newswire / August 4, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on October 5, 2026 to stockholders of record at the close of business on September 17, 2026. This is a 1.6% increase over the dividend declared in the same quarter of the prior year.

Utah Medical Products, Inc. Announces Quarterly Dividend

Zacks Investment Research

Utah Medical's Q2 Earnings Down Y/Y Due to Customer Losses

UTMD's Q2 earnings per share decline 10.1% year over year, while quarterly revenues face pressure from lost customers and slower new business growth.

Utah Medical's Q2 Earnings Down Y/Y Due to Customer Losses

UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2026

SALT LAKE CITY, UT / ACCESS Newswire / July 23, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) reports second calendar quarter (2Q) and first half (1H) 2026 financial results with a continued decline in overall revenues in comparison to the same time periods in 2025. Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros.

UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2026

Utah Medical Products, Inc. Announces Quarterly Dividend

SALT LAKE CITY, UT / ACCESS Newswire / May 5, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on July 3, 2026 to stockholders of record at the close of business on June 17, 2026. This is a 1.6% increase over the dividend declared in the same quarter of the prior year.

Utah Medical Products, Inc. Announces Quarterly Dividend

Zacks Investment Research

Utah Medical's Q1 Earnings Fall Y/Y Due to Elevated Litigation Costs

UTMD reports a year-over-year decline in Q1 earnings per share and sales, pressured by lost distributor business and higher costs, despite improved margins and a strong balance sheet.

Utah Medical's Q1 Earnings Fall Y/Y Due to Elevated Litigation Costs

Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2026

SALT LAKE CITY, UT / ACCESS Newswire / April 23, 2026 / In the first calendar quarter (1Q) of 2026, Utah Medical Products, Inc. (Nasdaq:UTMD) attained financial results which were consistent with its previously announced projections for calendar year 2026. But because of the relatively short span of time, results for any given three-month period in comparison with a previous three-month period may not be indicative of comparative results for the year as a whole.

Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2026

Zacks Investment Research

Utah Medical Gains 32% in a Year: Should You Buy the Stock?

UTMD's niche leadership, global footprint, and strong cash generation position it to benefit from rising demand for high-quality maternal and neonatal healthcare solutions.

Utah Medical Gains 32% in a Year: Should You Buy the Stock?

Zacks Investment Research

The Zacks Analyst Blog American Express, Intuitive Surgical, Shopify and Utah Medical Products

American Express leads featured reports as spending growth and digital investments drive gains, while Intuitive Surgical and Shopify show mixed momentum.

The Zacks Analyst Blog American Express, Intuitive Surgical, Shopify and Utah Medical Products

Zacks Investment Research

Utah Medical's Q4 Earnings Hurt by OEM Decline, Fall Y/Y

UTMD's Q4 earnings fall year over year due to weak OEM sales and lower international Filshie sales, but strong U.S. Filshie growth and steady margins help offset broader revenue pressure.

Utah Medical's Q4 Earnings Hurt by OEM Decline, Fall Y/Y

See News Rankings

Price charts implemented using Lightweight Charts™